ALPK3: a full spectrum cardiomyopathy gene?
Open Access
- 15 July 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (32) , 3074-3077
Abstract
This editorial refers to ‘Alpha-protein kinase 3 (ALPK3)-truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy’, by L.R. Lopes et al. doi:10.1093/eurheartj/ehab424.Keywords
Funding Information
- Dutch Heart Foundation
- Netherlands Organization for Scientific Research (016.150.610)
- Fondation Leducq (17CVD02)
- Horstingstuit Foundation
- Amsterdam Cardiovascular Sciences fellowship
This publication has 11 references indexed in Scilit:
- Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivityNature Genetics, 2021
- A Pathogenic Variant inALPK3Is Associated With an Autosomal Dominant Adult-onset Hypertrophic CardiomyopathyCirculation: Genomic and Precision Medicine, 2020
- Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variantsAmerican Heart Journal, 2020
- Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathyHeart, 2020
- Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathyNature Communications, 2020
- Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy GenesCirculation: Genomic and Precision Medicine, 2019
- Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic CardiomyopathyJACC, 2018
- Modified penetrance of coding variants by cis-regulatory variation contributes to disease riskNature Genetics, 2018
- Biallelic Truncating Mutations in ALPK3 Cause Severe Pediatric CardiomyopathyJACC, 2016
- Quantifying prion disease penetrance using large population control cohortsScience Translational Medicine, 2016